Evoke Pharma Inc (EVOK)
5.84
+0.12
(+2.10%)
USD |
NASDAQ |
Nov 05, 11:46
Evoke Pharma Market Cap: 4.291M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.203M |
| November 01, 2024 | 4.262M |
| October 31, 2024 | 4.299M |
| October 30, 2024 | 4.740M |
| October 29, 2024 | 4.629M |
| October 28, 2024 | 5.202M |
| October 25, 2024 | 3.894M |
| October 24, 2024 | 3.770M |
| October 23, 2024 | 3.770M |
| October 22, 2024 | 3.968M |
| October 21, 2024 | 4.027M |
| October 18, 2024 | 4.049M |
| October 17, 2024 | 3.921M |
| October 16, 2024 | 3.777M |
| October 15, 2024 | 3.755M |
| October 14, 2024 | 3.740M |
| October 11, 2024 | 3.814M |
| October 10, 2024 | 3.909M |
| October 09, 2024 | 3.799M |
| October 08, 2024 | 4.093M |
| October 07, 2024 | 3.953M |
| October 04, 2024 | 3.858M |
| October 03, 2024 | 3.821M |
| October 02, 2024 | 3.637M |
| October 01, 2024 | 3.578M |
| Date | Value |
|---|---|
| September 30, 2024 | 3.498M |
| September 27, 2024 | 3.534M |
| September 26, 2024 | 3.733M |
| September 25, 2024 | 3.527M |
| September 24, 2024 | 3.674M |
| September 23, 2024 | 3.865M |
| September 20, 2024 | 3.314M |
| September 19, 2024 | 3.262M |
| September 18, 2024 | 3.116M |
| September 17, 2024 | 3.204M |
| September 16, 2024 | 3.102M |
| September 13, 2024 | 3.167M |
| September 12, 2024 | 3.079M |
| September 11, 2024 | 2.954M |
| September 10, 2024 | 3.013M |
| September 09, 2024 | 3.02M |
| September 06, 2024 | 2.844M |
| September 05, 2024 | 2.866M |
| September 04, 2024 | 2.932M |
| September 03, 2024 | 3.038M |
| August 30, 2024 | 3.152M |
| August 29, 2024 | 3.167M |
| August 28, 2024 | 3.230M |
| August 27, 2024 | 3.374M |
| August 26, 2024 | 3.402M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.106M
Minimum
Jan 29 2024
148.24M
Maximum
Aug 14 2020
30.11M
Average
13.71M
Median
Feb 07 2023
Market Cap Benchmarks
| Repligen Corp | 8.010B |
| NovaBay Pharmaceuticals Inc | 3.762M |
| Palatin Technologies Inc | 23.07M |
| iBio Inc | 23.15M |
| Theriva Biologics Inc | 2.020M |
Market Cap Related Metrics
| PS Ratio | 0.2770 |
| Price to Book Value | 1.610 |
| Price | 5.84 |
| Earnings Yield | -452.1% |